Octavio Seung Choi

Dr. Octavio Seung Choi is a psychiatrist based in Palo Alto, California, holding both MD and PhD degrees. His clinical and research work spans psychiatry, with a notable presence in forensic psychiatry contexts, including contributions to academic discussion on forensic fellowship training and applicant matching processes published in the Journal of the American Academy of Psychiatry and the Law.

Dr. Choi has also been involved in clinical trial research related to dermatologic conditions, particularly psoriasis. He is a contributing author on multiple publications from the VISIBLE and SPECTREM clinical trials, which examined the efficacy and safety of guselkumab for moderate to severe psoriasis across diverse skin tones and high-impact anatomical sites. That work, published in JAMA Dermatology, the British Journal of Dermatology, and Dermatology and Therapy, includes a focus on improving racial and ethnic diversity in clinical trial enrollment. Additional published work touches on neuroinflammatory mechanisms in amyotrophic lateral sclerosis. Across more than three dozen peer-reviewed publications, Dr. Choi has contributed to research at the intersection of psychiatry, immunology, and clinical trial methodology. He is licensed in California.